- Home
- CSR vs SYRE Comparison
CSR vs SYRE Comparison
Compare CSR & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSR
- SYRE
- Stock Information
- Founded
- CSR 1970
- SYRE 2013
- Country
- CSR United States
- SYRE United States
- Employees
- CSR N/A
- SYRE N/A
- Industry
- CSR Real Estate Investment Trusts
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- CSR Real Estate
- SYRE Health Care
- Exchange
- CSR Nasdaq
- SYRE Nasdaq
- Market Cap
- CSR 953.1M
- SYRE 897.9M
- IPO Year
- CSR N/A
- SYRE 2016
- Fundamental
- Price
- CSR $59.97
- SYRE $14.22
- Analyst Decision
- CSR Buy
- SYRE Buy
- Analyst Count
- CSR 9
- SYRE 8
- Target Price
- CSR $72.22
- SYRE $50.00
- AVG Volume (30 Days)
- CSR 110.9K
- SYRE 859.8K
- Earning Date
- CSR 05-01-2025
- SYRE 05-08-2025
- Dividend Yield
- CSR 5.09%
- SYRE N/A
- EPS Growth
- CSR N/A
- SYRE N/A
- EPS
- CSR N/A
- SYRE N/A
- Revenue
- CSR $260,983,000.00
- SYRE N/A
- Revenue This Year
- CSR $4.47
- SYRE N/A
- Revenue Next Year
- CSR $3.67
- SYRE N/A
- P/E Ratio
- CSR N/A
- SYRE N/A
- Revenue Growth
- CSR N/A
- SYRE N/A
- 52 Week Low
- CSR $54.13
- SYRE $10.91
- 52 Week High
- CSR $76.16
- SYRE $40.49
- Technical
- Relative Strength Index (RSI)
- CSR 47.99
- SYRE 45.86
- Support Level
- CSR $56.65
- SYRE $12.04
- Resistance Level
- CSR $59.52
- SYRE $13.29
- Average True Range (ATR)
- CSR 2.92
- SYRE 1.24
- MACD
- CSR 0.20
- SYRE 0.32
- Stochastic Oscillator
- CSR 63.00
- SYRE 80.54
About CSR D/B/A Centerspace
Centerspace is a real estate investment trust (REIT) that focuses on the ownership, management, acquisitions, redevelopment, and development of apartment communities. The company operates through a single reportable segment which includes the ownership, management, development, redevelopment, and acquisition of apartment communities and conduct their corporate operations from offices in Minot, North Dakota and Minneapolis, Minnesota.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.